Common Contracts

26 similar Collaboration and Licensing Agreement contracts

Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021
Takeda inks deal worth $1.04B with Arrowhead for liver disease therapy
Collaboration and Licensing Agreement • May 17th, 2021